Abstract
Cardiometabolic diseases share many modifiable risk factors. However, periodontitis, a chronic inflammatory condition of the gums, is a risk factor that is rarely publicized. This systematic review aims to evaluate the impact of oral hygiene practices on the risk, incidence, and/or mortality rate of cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD). Searches were conducted using MEDLINE, Embase, Scopus, and CINHAL. Randomized controlled trials (RCTs), quasi-RCTs, and observational studies were included. Eligible studies reported on associations of toothbrushing, interdental cleaning, mouthwash, or toothpaste use, either alone or in combination with CVD, CKD, and/or T2DM outcomes in adults ≥ 18 years. Fifty-five studies were included. Cochrane’s risk of bias tool and the Newcastle–Ottawa Scale were used for quality assessment. Data synthesis is narratively presented. Toothbrushing and interdental cleaning were associated with lower risk of developing T2DM or hypertension HR 0.54 [p < 0.001] and a lower mortality risk in those with CVD HR = 0.25 [p = 0.03]. Mouthwash use reportedly increased the risk of developing hypertension and diabetes by 85% and 55%, respectively. This review highlights how simple oral hygiene practices can reduce cardiometabolic risk. Non-dental clinicians could integrate the findings into chronic disease health promotion.
1. Introduction
Cardiometabolic diseases encompass a group of interrelated conditions including cardiovascular disease (CVD), diabetes mellitus (DM), and chronic kidney disease (CKD) [1], and are increasingly occurring in combination [2]. These conditions are the leading cause of death and disability worldwide [3,4,5], and collectively were responsible for almost half of all Australian deaths in 2022 [6,7,8]. Cardiometabolic diseases share many highly publicised, modifiable risk factors, including tobacco and alcohol consumption, diet, and sedentary lifestyle [6,7,8]. However, oral disease, specifically periodontal disease, (PD) [9] which is another important modifiable risk factor, is seldom mentioned [6,7,8]. Categorised as gingivitis or periodontitis, PD affects 90% of any population [10]. The more severe form of PD, periodontitis, which affects between 20 and 50% of the global population [11], has strong associations with CVD [12,13] and a well-established bi-directional relationship with DM [14]; and there is also emerging evidence of a bi-directional link with CKD [15,16].
Preventing PD and other oral disease [17] begins with simple oral hygiene practices including toothbrushing (TB) with toothpaste, interdental cleaning, and, under certain circumstances, mouthwash use which together maintain a healthy oral biofilm [18,19,20,21]. Poor oral hygiene practices allow bacterial deposits to accumulate on the soft and hard tissues of the oral cavity resulting in PD. A biofilm that remains stagnant for 24–48 h, initiates a host immune response, triggering a local inflammatory reaction which in turn initiates systemic inflammation [22]. The local vasodilation enables bacteria within stagnant biofilm to enter the bloodstream [22] and reach distant organs such as the heart and pancreas [13]. Inflammation is therefore the mechanism that links the more severe form of PD, namely periodontitis, and cardiometabolic conditions such as CVD, CKD, and type 2 diabetes mellitus (T2DM) [13,23]. Whilst previous studies investigated oral hygiene practices in combination with other therapies [24], or focus on a single cardiometabolic condition [25], this study is the first systematic review to evaluate the effect oral hygiene practices alone may have on a range of cardiometabolic conditions. The aim of this review is to identify the impact of oral hygiene practices on the risk, incidence, and/or mortality rate of CVD, T2DM, and CKD.
2. Materials and Methods
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement [26]. The review protocol is registered with an international register of systematic reviews (PROSPERO ID: CRD42021269584).
2.1. Inclusion and Exclusion Criteria
Peer-reviewed randomized controlled trials (RCTs), quasi-RCTs, observational, cohort, case–control, and cross-sectional studies were eligible for inclusion meeting the following criteria: adults ≥18 years, examined the influence of oral hygiene practices (toothbrushing, interdental cleaning, mouthwash, or toothpaste use, either alone or in combination) on cardiometabolic disease, specifically CVD, CKD, and/or T2DM. Conference abstracts, case-studies/series, letters to the editors, editorials, and animal studies were excluded. Studies which reviewed scaling and root debridement/planning, periodontal surgery, or other dental treatments alone, or focused on other cardiometabolic conditions or non-cardiometabolic diseases were excluded.
2.2. Search Strategy
The initial search was performed on 27 July 2021 and repeated in 2022 and 2023. The final search, occurring on 10 July 2024, was carried out on the following electronic databases: MEDLINE, Embase, Scopus, and CINHAL. No restrictions were placed on language or publication period, and no human filter was applied. Mirroring terms were used for electronic databases; Google Scholar was explored for grey literature. Citation lists of relevant studies were also examined. The search strategy included Boolean operators, medical subject headings, and truncations, and included terms relating to, or describing, oral health practices and cardiometabolic diseases, including CVD, T2DM, and CKD. Every attempt was made to retrieve inaccessible studies. For the full search strategy, see Supplementary Material S1.
2.3. Data Extraction and Synthesis
A data extraction tool developed within Covidence was completed independently by LC and one of five other reviewers (BS, KC, KF, JM, RB). Key characteristics extracted were author[s], publication year, country, study design, aim[s], setting, age, sex, oral hygiene practices, disease biomarkers, and oral health status. Due to the heterogeneity in included study designs and outcomes, a meta-analysis was not feasible. Data synthesis has been presented narratively with reference to Supporting Material.
2.4. Quality Appraisal and Risk of Bias
Study quality was assessed independently by LC and one of five other reviewers (BS, KC, KF, JM, RB). RCT quality (n = 3) was assessed using an adapted Cochrane’s risk of bias tool [27]. The Newcastle–Ottawa Scale (NOS) [28] was used for all other included studies (n = 52). Any disagreements were resolved via open discussion and where consensus was unsuccessful a third investigator (SK or NM) was involved.
3. Results
3.1. Selection Process
Using systematic review software Covidence [29], 8659 citations were imported into the program, 4280 duplicates were removed and 4379 were screened. Title and abstract screening, followed by full-text screening, was completed independently by two reviewers from a pool of eight (BS, KC, KF, JM, LC, NM, RB, SK). A total of 55 studies (32 cohort [30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61], 13 cross-sectional studies [62,63,64,65,66,67,68,69,70,71,72,73,74,75], 3 case–control [76,77,78], 1 prospective [79], 2 observational [80,81], 1 quasi-experimental [82], and 3 RCTs [83,84]) met the inclusion criteria. See Figure 1 for the PRISMA flow diagram. Conflicts arising during the screening process were resolved via group discussion.
Figure 1.
PRISMA Flow diagram.
3.2. Characteristics
Fifty-five studies spanning between 2003 and 2024 were identified, taking place in Europe [45,46,50,65,76], Asia [31,32,34,36,39,40,43,44,47,48,49,52,53,54,55,56,57,58,59,60,61,62,63,67,68,69,70,71,72,73,77,78,81,82,84], United States [30,51,66,74,75], South America [33,38,41,42,45], and the Middle East [35,64,79,80,83]. Study populations ranged from n = 60 to n = 487,198; the mean and median age ranges were 41.5 ± 9.3–67.71 ± 10.6 and 63–68, respectively. Eleven studies had a majority of female participants, twenty-eight had a majority of male participants, two included only male participants and four did not disclose sex. Thirty-four studies focused on CVD [31,36,37,40,42,43,44,46,47,49,51,52,53,54,55,56,57,59,60,61,62,65,66,67,68,69,71,72,73,76,77,78,81], twenty-three on DM [30,32,34,35,41,43,47,48,49,50,53,57,63,64,67,68,69,70,72,74,75,79,82,83,84], and nine on CKD [33,38,39,45,49,58,69,80,81]. Oral hygiene practices investigated included TB [31,32,33,34,35,36,37,39,40,43,44,45,46,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,63,64,65,66,67,68,69,70,72,73,74,76,77,77,78,78,79,80,81,82,83,84], interdental cleaning [30,33,34,38,45,46,51,62,66,71,74,75,76,81,82], mouthwash [33,41,42,45,51,62,76,78,79,81,82,84], and fluoridated toothpaste use [34,77,78]. See Table 1 for study characteristics.
Table 1.
Study characteristics.
Two studies reported oral hygiene practices as a proxy for oral hygiene status score [51,81], thus not directly relating specific practices with the disease outcome. Additionally, two discussed the relationship of oral hygiene practice to oral conditions (non-defined periodontal symptoms and tooth loss) [63,71], which were associated with the disease outcome; see Table 2 for study findings.
Table 2.
Study findings.
Of the total studies, thirty-nine [30,31,33,36,37,38,39,40,41,42,43,46,48,49,50,52,53,54,55,56,57,58,59,60,61,62,65,66,67,68,71,72,73,74,75,76,77,78,80] were considered good quality, eight [37,45,47,48,63,69,70,81] were considered fair, and the remaining five [34,35,51,64,79] were rated poor quality; see Table 3 for NOS quality assessment.
Table 3.
Quality assessment of included non-RCT studies using NOS.
The RCTs’ overall risk of bias was determined high [n = 1] [83] and low [n = 2] [82,84]; see RoB in Figure 2. Created using the robvis tool with permission [85].
Figure 2.
RCT risk of bias.
3.3. Toothbrushing Frequency
Forty-three studies examined TB practices reported as daily frequency [31,32,33,34,35,36,37,39,40,43,44,45,46,47,48,49,50,51,52,53,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,72,73,74,76,77,78,79,80,81,82,83], device used [51,77,78,84], technique [63,77], time of day [54,70,77], and/or duration [45,55]. Increased TB frequency (ranging from sometimes/daily—≥3× daily) was linked to reduced risk of developing CVD [68,78,81] and/or hypertension. [31,53,56,67] It was also shown to reduce the risk of stroke [36,40,52,59,62,77], atrial fibrillation [37], and/or heart failure (HF) occurrence [37,57], cardiovascular events [40,44,49,51,52,55,65,74], including death [51,60,61,73,76], and all-cause deaths [49,60]. Seven studies reported no link between low TB frequency (ranging from never to 2× daily) and increased risk of hypertension [43], acute coronary syndrome [40], cardiovascular death [45], subarachnoid haemorrhage, ischemic heart disease [49,60], haemorrhagic stroke [59], or other CVD outcomes [46].
For individuals living with DM, higher daily TB frequency was found to significantly lower the risk of cerebral or myocardial infarction [47] as well as HF [57]. One study found lower daily TB frequency was a risk factor for developing DM in males, but not females [43], whilst two discussed no relationship between TB frequency and T2DM [49,74]. Several studies highlighted either increased DM prevalence associated with lower TB frequency [67,69,72] or reduced DM incidence associated with higher TB frequency [31,32,50,53]. Similarly, in those living with end-stage kidney disease (ESKD), individuals with higher TB frequency had lower prevalence of hypertension, DM [39], rates of hospitalisations [33], and longer all-cause survival [45]; however, there was no impact on cardiovascular death risk.
Conversely, one study reported that TB frequency was most the important factor for all-cause peritonitis, streptococcal peritonitis, CHF, and pneumonia in individuals with ESKD [81]. Two [49,69] found no association between TB frequency and CKD, whilst another reported an inverse relationship between TB frequency and developing CKD [58]. Interestingly, one study concluded TB only 1–2× daily was associated with better kidney function [39].
Twenty studies reported on biomarkers linked to CVD, DM, and CKD. These included C-reactive protein (CRP) or high-sensitivity C-reactive protein (hs-CRP), interleukin (IL), blood glucose, cholesterol, lipids, and others. Seven studies reported a significant inverse relationship between TB frequency and circulating CRP/hs-CRP [55,65,73,73,76,80,81].
One study linked TB frequency with undefined periodontal symptoms, which were found to be associated with higher glycated haemoglobin (HbA1c) levels [63]. The other studies reported lower Hb1Ac [35,82,83], fasting plasma glucose (FPG) [82], or fasting blood glucose (FBGL) [48,73] with more frequent TB. One study concluded those who did not brush daily had a 79% increased risk of higher HbA1c [79], similar to another study [34].
Biomarkers related to dyslipidaemia are heavily involved with cardiometabolic conditions and were discussed in seven studies [43,64,66,67,69,73,79]. Whilst one study reported total cholesterol was not significantly impacted by TB frequency [67], others found that less frequent TB was associated with elevated total cholesterol [66], lower HDL [64,67,73,79], high LDL [79], and high triglycerides [67,73]. Two studies found reduced TB frequency was associated with dyslipidaemia [43,69]. Interestingly; however, one found frequency was linked to developing the condition in females only [43].
The impact of TB frequency on other cardiometabolic disease biomarkers had similar results. Less frequent TB was associated with increased concentrations of white blood cells [73], adiponectin [66], fibrinogen, higher levels of IL-1β, and a trend toward an association with a higher level of tissue plasminogen activator inhibitor-1 (tPAI-1) [65]. A better oral hygiene score was significantly associated with lower albumin levels [81] and had an inverse correlation with oral innate immunity marker salivary lysozyme [76]. Additionally, increased TB frequency was associated with higher estimated glomerular filtration rate [eGFR] and milder stage of CKD compared to less frequent TB [39].
3.4. Toothbrushing Device
Three studies examined the impacts of TB devices on CVD, whilst one focused on T2DM. One study found, compared to controls, participants living with stroke were less likely to use a toothbrush, leading to poor oral health status and increased periodontal disease [77]. Another reported that the use of other toothbrushing devices such as a neem stick or miswak increased the risk of developing CHD [78], whilst using an electric toothbrush was found to be associated with a decrease in non-specified CVD outcomes and better survival when combined with other oral hygiene practices [51]. When comparing electric and manual tooth brushes, one study found significant reduction in HbA1c in both study arms at the final follow-up; however, no significant reductions in CRP and IL-β levels were found [84].
3.5. Toothbrushing Technique
Toothbrushing technique (non-rolling or rolling stroke) had no significant effect on self-reported periodontal symptoms [63] and no significant differences were detected between individuals living with or without stroke in terms of their toothbrushing technique (horizontal or other) [77].
3.6. Timing
The timing of toothbrushing was assessed in three studies. When defined as before or after meals, one study found no association with toothbrush timing and individuals living with stroke, compared to those without stroke [77]. Defined as brushing before bed (sometimes/no or always) in a T2DM cohort, those who brushed their teeth every night before bed had lower BMI and LDL than those who did not brush nightly [70]. The third study categorised TB timing as Group MN (morning and night)/Group M (morning only)/Group Night (night only)/Group None (not brushing) and reported higher survival estimates following cardiovascular events in Group MN and Group N [54].
3.7. Duration
The duration of TB was assessed in two studies. In individuals living with ESKD, there was an association between longer survival and lower risk of cardiovascular death when TB for ≥2 min [45]. For individuals living with CVD, brushing < 2× daily for <2 min was associated higher risk of cardiovascular events compared to those TB for ≥2 min ≥2× daily [55]. However, no differences were detected for cardiovascular events when comparing brushing < 2× daily for <2× min with brushing either twice daily or for two minutes.
3.8. Interdental Cleaning
Interdental cleaning was evaluated in fourteen studies. As the primary focus of [30,38,75], dental floss use was associated with lower HbA1c levels [75] and lower risk of elevated CRP [30], and its lack of use was associated with an increased risk for patient mortality [38]. As a proxy for remaining teeth, seldom/occasional dental floss use before bed was indirectly linked to higher risk of stroke [71]. Secondary to other oral hygiene practices, dental floss or interdental brush use was associated with reduced hospitalisations [33], decreased risk of CVD mortality [45,46,51,76], increased adiponectin and fibrinogen levels [54], and longer survival rates if living with ESKD [45]. In contrast, less-frequent flossing was associated with elevated mean arterial pressure. Increased daily use of dental floss in a diabetic population was indirectly linked to the decrease in FPG and HbA1c [82].
Furthermore, the use of dental floss was linked to health outcomes when grouped with other practices to develop an oral hygiene score [51,81]. For individuals living with CKD completing peritoneal dialysis, an oral hygiene score of ≥7 was associated with lower hospitalisation and mortality rates [81]. One study reported individuals who had a high oral hygiene score had a 79% decreased risk of CVD morality [51]. Similarly, when grouped with other dental products, one study reported an association with interdental cleaning and stroke [62].
3.9. Mouthwash and Toothpaste
Daily mouth wash use was discussed in twelve studies. Three incorporated the practice with either auxiliary products [62] or other practices [81,82], indirectly linking its use to improved glycaemic control [82], reduced CVD admissions, and mortality rates [81], as well as an association with stroke [62]. Significant reductions in H1bAc levels at follow-up were reported by one study when using mouthwash via a water flosser and a powered brush twice daily [84]; however, no significant reductions were reported in CRP or IL-β. Two studies found mouthwash use corresponded with better survival [45] and lower hospitalisations [33] in individuals living with ESKD and CKD. Two studies [41,42] found that its use was associated with a 55% and 85% higher risk of developing new-onset DM or hypertension, respectively, as well as increased blood pressure [42]. However, other studies found no independent link between mouthwash use and CVD outcomes [51,76]. One study included both mouthwash and toothpaste use, though it did not link them to HbA1c [34]. Two [77,78] found no independent link with toothpaste use and disease outcomes.
4. Discussion
This systematic review is the first to assess the impact of oral hygiene practices on the risk, incidence, and/or mortality rate of cardiometabolic conditions CVD, T2DM, and CKD, and highlights the significant effects some of these practices have on cardiometabolic disease outcomes.
4.1. Main Findings
Frequency of TB was the primary focus of most studies [31,32,33,34,35,36,37,39,40,43,44,45,46,47,48,49,50,51,52,53,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,72,73,74,76,77,78,79,80,81,82,83]. Although there were some conflicting results [40,43,45,46,49], the overwhelming consensus was that increased TB frequency had positive impacts on CVD [31,36,37,40,43,44,47,49,52,53,54,55,56,57,59,60,61,62,65,66,67,68,69,72,73,77,78], DM [30,31,32,34,35,43,47,48,49,50,53,57,63,64,67,69,72,74,79,82,83], and CKD [33,39,45,49,58,69,80,81] outcomes. These findings support the role oral bacteria play in cardiometabolic disease if allowed to remain stagnant. Furthermore, the combination of increased TB frequency and daily interdental cleaning was associated with a further decrease in CVD mortality risk compared to brushing alone [76]. This result is likely due to interdental cleaning reaching areas where toothbrushes cannot [20].
Increased frequency of oral hygiene practices was also found to reduce inflammatory markers such as CRP [30,55,65,66,73,76,80,81], further supporting the role of oral bacteria in driving systemic inflammation. Elevation of CRP levels are associated with the development of cardiometabolic conditions [86,87], having detrimental consequences for those already living with CVD [87], DM [86], and CKD [88].
Interestingly, for individuals living with CKD, there were contradictory findings. Two studies found TB ≥ 3 times daily had positive CKD outcomes [33,58], whilst another reported TB after every meal was more detrimental to kidney function than TB 1–2× daily [39]. This may be due to disruption of the oral microbiome as overbrushing has been reported to reduce beneficial bacteria [89]. The other studies involving CKD do not define TB frequency [45] or incorporate it into an oral hygiene score [80,81], and as such, additional studies with standardised TB frequency categories are required to clarify these opposing findings.
The benefits of mouthwash use on cardiometabolic disease outcomes is inconclusive with studies reporting positive [33,45,81,84], neutral [51,76], and negative [41,42] health outcomes. The indeterminate bactericidal nature of mouthwash which can disrupt the healthy oral microbiome is thought to be the reason for the negative health outcomes.
The oral microbiome is a complex mix of beneficial bacteria and other microorganisms residing in the oral cavity [90]. This microbiome, as well as protective enzymes in saliva [91], make up part of a nonimmune defence system against invasion from harmful bacteria and pathogens [90,91]. Mouthwash use disrupts the oral microbiome by eliminating both beneficial and harmful bacteria [92] and may explain why ≥2× daily use was found to increase the risk of hypertension and DM [41,42].
4.2. Risk Factor Comparison
Diet and exercise are well-known modifiable risk factors for cardiometabolic diseases [6,7,8]. Recent literature found individuals with a higher diet score (≥5) were at a lower risk of mortality (HR 0.70;0.63–0.77), CVD (HR 0.82; 0.75–0.91), MI (HR 0.86; 0.75–0.99) and stroke (HR 0.81; 0.71–0.93) [93]; having a combination of a healthy diet and active lifestyle significantly lowered the risk of all-cause mortality (HR 0.74; 0.65–0.86) and CVD deaths (HR 0.79; 0.73 to 0.86) [94].
Similar HRs were found in the included studies, reporting that individuals with increased oral hygiene practices had a lower risk of all-cause death (HR 0.76; 0.58–0.99) [45], CVD mortality (HR 0.25; 0.07–0.89) [76], MI (HR: 0.76; 0.62–0.94), and cerebral infarction (HR: 0.81, 95% CI: 0.69–0.94) [35]. However, oral health education is rarely provided for chronic disease management, and easily accessible information is scarce [6,7,8].
5. Clinical Significance
This review has highlighted that simple oral hygiene practices are associated with better cardiometabolic health outcomes and can reduce systemic inflammation. Therefore, non-dental clinicians are encouraged to recommend daily interdental cleaning followed by ≥2× daily TB to for at least two minutes for patients living with cardiometabolic conditions.
6. Strengths and Limitations
The strength of this systematic review is that it is the first review to summarise the impact oral health practices have on the risk, incidence, and mortality rate of CVD, DM, and/or CKD. This review followed a PROSPERO registered protocol. Two thirds of the included studies were rated as good quality. The global origin of the literature enables this review to be more generalisable. Although there was heterogeneity when reporting TB frequency, the overwhelming consensus found increased TB frequency (≥2× daily) and daily interdental cleaning had a positive effect on cardiometabolic disease outcomes.
However, there are limitations which need to be considered when interpreting the results. Many of the studies that reported on DM did not specify the type; it is therefore possible that the impact of oral hygiene varies depending on the condition of DM. Although the literature is global in nature, this review does not account for individual countries’ healthcare and belief systems, which may influence oral hygiene practices. Reporting bias is a part of all the included studies, as they relied on self-report data for oral hygiene practices. Furthermore, due to the heterogeneity within the study data collection and reporting, there is a need for further research using standardised oral hygiene questionnaires. Finally, and importantly, only three RCTs were identified. This highlights a great need for further clinical research to better understand causal relationships between oral health and cardiometabolic disease.
7. Conclusions
This systematic review has highlighted that for individuals living with or at risk of CVD, T2DM, and/or CKD, increased daily TB frequency (≥2× daily) as well as daily interdental cleaning is associated with reduced systemic inflammation, better health outcomes, and a lowered mortality risk. Cardiometabolic diseases are the leading causes of death and disability worldwide, and as such, provision of basic oral hygiene advice should be included in chronic disease prevention programs. Furthermore, development and implementation of interventional research involving cardiometabolic diseases and oral hygiene practices are needed to further strengthen the findings of this review.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijerph21101319/s1.
Author Contributions
L.C., S.K., and N.M. conceptualised the systematic review. All authors completed screening for review. L.C., K.F., B.S., K.C., J.M., and R.B. performed data extraction. L.C. wrote the manuscript using synthesised data; S.K. provided guidance to L.C. Included tables were initiated by B.S., K.C., J.M., and R.B. then completed by L.C. L.C., S.K. and K.F., and N.M. revised the draft. All authors have read and agreed to the published version of the manuscript.
Funding
The post-doctoral research positions of S.K. and L.C.’s Ph.D. scholarships are supported by donations from the Bella-Schwarz Foundation. The foundation had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
No new data were created for this review.
Acknowledgments
The authors express their gratitude to Kanchana Ekanayake, Academic Liaison Librarian at the University of Sydney Library, for her expertise in developing the search strategy for this review. The authors would also like to thank Nusrat Mahiuddin for help with initial searches.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Agrawal, A.; Rao, G. Novel Approaches for Early Diagnosis and Prevention of Cardiometabolic Diseases. J. Clin. Prev. Cardiol. 2023, 12, 23–26. [Google Scholar] [CrossRef]
- Barnett, K.; Mercer, S.W.; Norbury, M.; Watt, G.; Wyke, S.; Guthrie, B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 2012, 380, 37–43. [Google Scholar] [CrossRef] [PubMed]
- Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020, 76, 2982–3021. [Google Scholar] [CrossRef] [PubMed]
- Ong, K.L.; Stafford, L.K.; McLaughlin, S.A.; Boyko, E.J.; Vollset, S.E.; Smith, A.E.; Dalton, B.E.; Duprey, J.; Cruz, J.A.; Hagins, H.; et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023, 402, 203–234. [Google Scholar] [CrossRef] [PubMed]
- Bello, A.K.; Okpechi, I.G.; Levin, A.; Ye, F.; Damster, S.; Arruebo, S.; Donner, J.-A.; Caskey, F.J.; Cho, Y.; Davids, M.R.; et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob. Health 2024, 12, e382–e395. [Google Scholar] [CrossRef]
- Heart, Stroke and Vascular Disease: Australian Facts. Australian Institute of Health and Welfare. June 2024. Available online: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/about (accessed on 1 September 2022).
- Australian Institute of Health and Welfare. Diabetes: Australian Facts. 17 June 2024. Available online: https://www.aihw.gov.au/reports/diabetes/diabetes/contents/impact-of-diabetes/diabetes-deaths (accessed on 19 August 2024).
- Australian Institute of Health and Welfare. Chronic Kidney Disease: Australian Facts, About. 17 June 2024. Available online: https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/about (accessed on 19 August 2024).
- Boyd, L.; Wilkins, E. Periodontal Disease Development. In Clinical Practice of The Dental Hygienist; Jones & Bartlett Learning, LLC: Burlington, VT, USA, 2020; pp. 659–706. [Google Scholar]
- Eke, P.I.; Borgnakke, W.S.; Genco, R.J. Recent epidemiologic trends in periodontitis in the USA. Periodontology 2000 2020, 82, 257–267. [Google Scholar] [CrossRef]
- Nazir, M.A. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int. J. Health Sci. 2017, 11, 72–80. [Google Scholar]
- Zhao, X.; Wang, J.; Xu, Y.; Zhou, J.; Hu, L. The role of periodontal disease in atherosclerotic cardiovascular disease. Biocell 2023, 47, 1431–1438. [Google Scholar] [CrossRef]
- Bui, F.Q.; Almeida-da-Silva, C.L.C.; Huynh, B.; Trinh, A.; Liu, J.; Woodward, J.; Asadi, H.; Ojcius, D.M. Association between periodontal pathogens and systemic disease. Biomed. J. 2019, 42, 27–35. [Google Scholar] [CrossRef]
- Păunică, I.; Giurgiu, M.; Dumitriu, A.S.; Păunică, S.; Pantea Stoian, A.M.; Martu, M.-A.; Serafinceanu, C. The Bidirectional Relationship between Periodontal Disease and Diabetes Mellitus—A Review. Diagnostics 2023, 13, 681. [Google Scholar] [CrossRef]
- Wahid, A.; Chaudhry, S.; Ehsan, A.; Butt, S.; Ali Khan, A. Bidirectional Relationship between Chronic Kidney Disease & Periodontal Disease. Pak. J. Med. Sci. 2013, 29, 211–215. [Google Scholar] [CrossRef] [PubMed]
- He, I.; Poirier, B.; Jensen, E.; Kaur, S.; Hedges, J.; Jesudason, S.; Jamieson, L.; Sethi, S. Demystifying the connection between periodontal disease and chronic kidney disease—An umbrella review. J. Periodontal Res. 2023, 58, 874–892. [Google Scholar] [CrossRef] [PubMed]
- Salhi, L.; De Carvalho, B.; Reners, M. Update on the Roles of Oral Hygiene and Plaque Control on Periodontal Disease. In Periodontitis: Advances in Experimental Research, 13th ed.; Santi-Rocca, J., Ed.; Springer International Publishing: Cham, Switzerland, 2022; pp. 329–339. ISBN 978-3-030-96881-6. [Google Scholar]
- Macarelli, C.; Boyd, L. Oral Infection Control: Toothbrushes and Toothbrushing. In Clinical Practice of the Dental Hygienist; Jones & Bartlett Learning, LLC: Burlington, VT, USA, 2020; pp. 929–983. [Google Scholar]
- Perry, K. Dentifrices and Mouthrinses. In Clinical Practice of the Dental Hygienist; Jones & Bartlett Learning, LLC: Burlington, VT, USA, 2020; pp. 1023–1059. [Google Scholar]
- Moravec, L.; Boyd, L. Oral Infection Control: Interdental Care. In Clinical Practice of the Dental Hygienist; Jones & Bartlett Learning, LLC: Burlington, VT, USA, 2020; pp. 984–1022. [Google Scholar]
- Berger, D.; Rakhamimova, A.; Pollack, A.; Loewy, Z. Oral Biofilms: Development, Control, and Analysis. High. Throughput 2018, 7, 24. [Google Scholar] [CrossRef] [PubMed]
- Miller, C.S.; Emecen-Huyja, P.; Gehrig, J.; Shin, D. Host Immune Response to Periodontal Pathogens. In Foundations of Periodontics for the Dental Hygienist; Wolters Kluwer | Lippincott WIlliams & Wilkins: Philadelphia, PN, USA, 2019; pp. 279–300. [Google Scholar]
- Tadakamadla, J.; Kumar, S.; Mamatha, G.P. Comparative evaluation of oral health status of chronic kidney disease (CKD) patients in various stages and healthy controls. Spec. Care Dent. 2014, 34, 122–126. [Google Scholar] [CrossRef] [PubMed]
- Joseph, P.; Prabhakar, P.; Holtfreter, B.; Pink, C.; Suvan, J.; Kocher, T.; Pitchika, V. Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of non-surgical periodontal treatment in patients with concurrent systemic conditions. Clin. Oral. Investig. 2023, 28, 21. [Google Scholar] [CrossRef]
- Liu, Y.; Wang, C.; Zhang, P.; Fu, W.; Zhang, J.; Zhang, Z.; Mao, J.; Yang, Y.; Zou, L. Association Between the Frequency of Tooth Brushing and the Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis. Angiology 2024. [Google Scholar] [CrossRef]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
- Boutron, I.; Page, M.J.; Higgins, J.P.T.; Altman, D.G.; Lundh, A.; Hróbjartsson, A. Chapter 7: Considering bias and conflicts of interest among the included studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 64; Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Page, M., Welsh, V., Eds.; Cochrane: Hoboken, NJ, USA, 2023; pp. 8:1–8:73, updated August 2023; Available online: www.training.cochrane.org/handbook (accessed on 1 January 2020).
- Wells, G.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses; Ottawa Hospital Research Institute: Ottawa, ON, Canada, 2021; Available online: https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp (accessed on 1 September 2024).
- Covidence Systematic Review Software; Veritas Health Innovation: Melbourne, Australia, 2023. Available online: https://www.covidence.org/ (accessed on 1 September 2024).
- Luo, H.; Wu, B.; Kamer, A.R.; Adhikari, S.; Sloan, F.; Plassman, B.L.; Tan, C.; Qi, X.; Schwartz, M.D. Oral Health, Diabetes, and Inflammation: Effects of Oral Hygiene Behaviour. Int. Dent. J. 2022, 72, 484–490. [Google Scholar] [CrossRef]
- Wang, Y.; Jiang, Y.; Chen, Y.; Yu, L.; Zhou, J.; Wang, N.; Liu, T.; Fu, C. Associations of oral hygiene with incident hypertension and type 2 diabetes mellitus: A population-based cohort study in Southwest China. J. Clin. Hypertens. 2022, 24, 483–492. [Google Scholar] [CrossRef]
- Chang, Y.; Lee, J.S.; Lee, K.-J.; Woo, H.G.; Song, T.-J. Improved oral hygiene is associated with decreased risk of new-onset diabetes: A nationwide population-based cohort study. Diabetologia 2020, 63, 924–933. [Google Scholar] [CrossRef]
- Assante, S.M.; Morimoto, S.; Tedesco, T.K.; Gimenez, T.; Ramalho, K.M. Correlations between dental assistance/oral health and clinical intercurrences in an end-stage kidney disease patients: A historical cohort study. Minerva Stomatol. 2020, 69, 100–105. [Google Scholar] [CrossRef] [PubMed]
- Aggarwal, A.; Panat, S.R. Oral health behavior and HbA1c in Indian adults with type 2 diabetes. J. Oral. Sci. 2012, 54, 293–301. [Google Scholar] [CrossRef] [PubMed]
- Almas, K.; Al-Lazzam, S.; Al-Quadairi, A. The effect of oral hygiene instructions on diabetic type 2 male patients with periodontal diseases. J. Contemp. Dent. Pract. 2003, 4, 24–35. [Google Scholar] [CrossRef] [PubMed]
- Chang, Y.; Woo, H.G.; Lee, J.S.; Song, T.J. Better oral hygiene is associated with lower risk of stroke. J. Periodontol. 2021, 92, 87–94. [Google Scholar] [CrossRef] [PubMed]
- Chang, Y.; Woo, H.G.; Park, J.; Lee, J.S.; Song, T.J. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study. Eur. J. Prev. Cardiol. 2020, 27, 1835–1845. [Google Scholar] [CrossRef]
- de Souza, C.M.; Braosi, A.P.R.; Luczyszyn, S.M.; Olandoski, M.; Kotanko, P.; Craig, R.G.; Trevilatto, P.C.; Pecoits-Filho, R. Association among oral health parameters, periodontitis, and its treatment and mortality in patients undergoing hemodialysis. J. Periodontol. 2014, 85, e169–e178. [Google Scholar] [CrossRef]
- Hirano, K.; Shimbo, T.; Komatsu, Y.; Kobayashi, D. Frequency of tooth brushing as a predictive factor for future kidney function decline. J. Nephrol. 2022, 35, 191–199. [Google Scholar] [CrossRef]
- Kobayashi, D.; Mizuno, A.; Mitsui, R.; Shimbo, T. Frequency of daily tooth brushing and subsequent cardiovascular events. Coron. Artery Dis. 2020, 31, 545–549. [Google Scholar] [CrossRef]
- Joshipura, K.J.; Munoz-Torres, F.J.; Morou-Bermudez, E.; Patel, R.P. Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. Nitric Oxide 2017, 71, 14–20. [Google Scholar] [CrossRef]
- Joshipura, K.; Munoz-Torres, F.; Fernandez-Santiago, J.; Patel, R.P.; Lopez-Candales, A. Over-the-counter mouthwash use, nitric oxide and hypertension risk. Blood Press 2020, 29, 103–112. [Google Scholar] [CrossRef]
- Kuwabara, M.; Motoki, Y.; Sato, H.; Fujii, M.; Ichiura, K.; Kuwabara, K.; Nakamura, Y. Low frequency of toothbrushing practices is an independent risk factor for diabetes mellitus in male and dyslipidemia in female: A large-scale, 5-year cohort study in Japan. J. Cardiol. 2017, 70, 107–112. [Google Scholar] [CrossRef] [PubMed]
- Park, S.-Y.; Kim, S.-H.; Kang, S.-H.; Yoon, C.-H.; Lee, H.-J.; Yun, P.-Y.; Youn, T.-J.; Chae, I.-H. Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: A population-based study from Korea. Eur. Heart J. 2019, 40, 1138–1145. [Google Scholar] [CrossRef] [PubMed]
- Palmer, S.C.; Ruospo, M.; Wong, G.; Craig, J.C.; Petruzzi, M.; De Benedittis, M.; Ford, P.; Johnson, D.W.; Tonelli, M.; Natale, P.; et al. Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study. Am. J. Kidney Dis. 2015, 66, 666–676. [Google Scholar] [CrossRef] [PubMed]
- Reichert, S.; Schlitt, A.; Beschow, V.; Lutze, A.; Lischewski, S.; Seifert, T.; Dudakliewa, T.; Gawe, R.; Werdan, K.; Hofmann, B.; et al. Use of floss/interdental brushes is associated with lower risk for new cardiovascular events among patients with coronary heart disease. J. Periodontal Res. 2015, 50, 180–188. [Google Scholar] [CrossRef]
- Song, T.J.; Jeon, J.; Kim, J. Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus. Diabetes Metab. 2021, 47, 101252. [Google Scholar] [CrossRef]
- Song, T.-J.; Chang, Y.; Jeon, J.; Kim, J. Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study. PLoS ONE 2021, 16, e0253769. [Google Scholar] [CrossRef]
- Zhuang, Z.; Gao, M.; Lv, J.; Yu, C.; Guo, Y.; Bian, Z.; Yang, L.; Du, H.; Chen, Y.; Ning, F.; et al. Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults. Eur. J. Clin. Investig. 2021, 51, e13634. [Google Scholar] [CrossRef]
- Winning, L.; Patterson, C.C.; Neville, C.E.; Kee, F.; Linden, G.J. Periodontitis and incident type 2 diabetes: A prospective cohort study. J. Clin. Periodontol. 2017, 44, 266–274. [Google Scholar] [CrossRef]
- Jangam, T.G. Oral Hygiene Home Care Practices and Cardiovascular Disease Mortality: A Cohort Study; Boston University School of Medicine: Boston, MA, USA, 2017; Available online: https://open.bu.edu/bitstream/handle/2144/26760/JANGAM_bu_0017N_13238.pdf?sequence=5 (accessed on 21 July 2023).
- Kim, J.; Kim, H.J.; Jeon, J.; Song, T.-J. Association between oral health and cardiovascular outcomes in patients with hypertension: A nationwide cohort study. J. Hypertens. 2022, 40, 374–381. [Google Scholar] [CrossRef]
- Guo, D.; Shi, Z.; Luo, Y.; Ding, R.; He, P. Association between oral health behavior and chronic diseases among middle-aged and older adults in Beijing, China. BMC Oral. Health 2023, 23, 97. [Google Scholar] [CrossRef]
- Isomura, E.T.; Suna, S.; Kurakami, H.; Hikoso, S.; Uchihashi, T.; Yokota, Y.; Sakata, Y.; Tanaka, S. Not brushing teeth at night may increase the risk of cardiovascular disease. Sci. Rep. 2023, 13, 10467. [Google Scholar] [CrossRef] [PubMed]
- Matsui, S.; Maruhashi, T.; Kishimoto, S.; Kajikawa, M.; Yusoff, F.M.; Nakashima, A.; Taguchi, A.; Higashi, Y. Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study. Int. J. Cardiol. 2022, 350, 111–117. [Google Scholar] [CrossRef] [PubMed]
- Hwang, S.; Oh, H.; Rhee, M.; Kang, S.; Kim, H.; Hwang, S.-Y.; Rhee, M.-Y.; Kim, H.-Y. Association of periodontitis, missing teeth, and oral hygiene behaviors with the incidence of hypertension in middle-aged and older adults in Korea: A 10-year follow-up study. J. Periodontol. 2022, 93, 1283–1293. [Google Scholar] [CrossRef] [PubMed]
- Huh, Y.; Yoo, J.E.; Park, S.-H.; Han, K.; Kim, S.M.; Park, H.S.; Cho, K.H.; Ahn, J.-S.; Jun, S.H.; Nam, G.E. Association of Dental Diseases and Oral Hygiene Care With the Risk of Heart Failure in Patients With Type 2 Diabetes: A Nationwide Cohort Study. J. Am. Heart Assoc. 2023, 12, e029207. [Google Scholar] [CrossRef]
- Chang, Y.; Lee, J.S.; Woo, H.G.; Ryu, D.-R.; Kim, J.-W.; Song, T.-J. Improved oral hygiene care and chronic kidney disease occurrence: A nationwide population-based retrospective cohort study. Medicine 2021, 100, e27845. [Google Scholar] [CrossRef]
- Long, M.; Wang, H.; Zhou, J.; Wu, Y.; Yu, L.; Liu, T. A prospective cohort study on the association between oral hygiene behaviors and the incidence of stroke. Chin. J. Dis. Control Prev. 2023, 27, 1167–1174. [Google Scholar] [CrossRef]
- Zhou, B.J.; Jiang, C.Q.; Jin, Y.L.; Au Yeung, S.L.; Lam, T.H.; Cheng, K.K.; Zhang, W.S.; Xu, L. Association of oral health with all-cause and cause-specific mortality in older Chinese adults: A 14-year follow-up of the Guangzhou Biobank Cohort study. J. Glob. Health 2024, 14, 04111. [Google Scholar] [CrossRef]
- Vogtmann, E.; Etemadi, A.; Kamangar, F.; Islami, F.; Roshandel, G.; Poustchi, H.; Pourshams, A.; Khoshnia, M.; Gharravi, A.; Brennan, P.J.; et al. Oral health and mortality in the Golestan Cohort Study. Int. J. Epidemiol. 2017, 46, 2028–2035. [Google Scholar] [CrossRef]
- Cho, M.J.; Kim, Y.S.; Park, E.Y.; Kim, E.K. Association between Periodontal Health and Stroke: Results from the 2013-2015 Korea National Health and Nutrition Examination Survey (KNHANES). J. Dent. Sci. 2021, 16, 268–274. [Google Scholar] [CrossRef]
- Choi, J.S. Relationship between hyperglycemia and periodontal symptoms in Korean type 2 diabetes mellitus patients aged >= 50 years. Indian. J. Public. Health Res. Dev. 2019, 10, 4387–4392. [Google Scholar] [CrossRef]
- Cinar, A.B.; Oktay, I.; Schou, L. Toothbrushing: A Link Between Noncommunicable and Communicable Diseases? Oral. Health Prev. Dent. 2015, 13, 515–522. [Google Scholar] [CrossRef] [PubMed]
- de Oliveira, C.; Watt, R.; Hamer, M. Toothbrushing, inflammation, and risk of cardiovascular disease: Results from Scottish Health Survey. BMJ 2010, 340, c2451. [Google Scholar] [CrossRef]
- Frisbee, S.J.; Chambers, C.B.; Frisbee, J.C.; Goodwill, A.G.; Crout, R.J. Research Association Between Dental Hygiene, Cardiovascular Disease Risk Factors and Systemic Inflammation in Rural Adults. J. Dent. Hyg. 2010, 84, 177–184. [Google Scholar] [PubMed]
- Fujita, M.; Ueno, K.; Hata, A. Lower frequency of daily teeth brushing is related to high prevalence of cardiovascular risk factors. Exp. Biol. Med. 2009, 234, 387–394. [Google Scholar] [CrossRef] [PubMed]
- Hwang, S.; Shim, J.; Kang, D.; Choi, J. Poor Oral Health Predicts Higher 10-Year Cardiovascular Risk A Propensity Score Matching Analysis. J. Cardiovasc. Nurs. 2018, 33, 429–436. [Google Scholar] [CrossRef]
- Kuwabara, M.; Motoki, Y.; Ichiura, K.; Fujii, M.; Inomata, C.; Sato, H.; Morisawa, T.; Morita, Y.; Kuwabara, K.; Nakamura, Y. Association between toothbrushing and risk factors for cardiovascular disease: A large-scale, cross-sectional Japanese study. BMJ Open 2016, 6, e009870. [Google Scholar] [CrossRef]
- Yoshioka, M.; Kawashima, Y.; Noma, Y.; Fukui, M.; Yanagisawa, S.; Shirayama, Y.; Nagai, K.; Hinode, D. Association between diabetes-related clinical indicators and oral health behavior among patients with type 2 diabetes. J. Med. Investig. 2021, 68, 140–147. [Google Scholar] [CrossRef]
- Huang, Y.-T.; Lin, M.-S.; James, K.; Chang, C.-H.; Tsai, W.-H.; Lin, Y.-C.; Chen, M.-Y. From self-care behaviours to cardiometabolic risks prevention for the health of farmers: Nursing implications. J. Adv. Nurs. 2023, 79, 3025–3034. [Google Scholar] [CrossRef]
- Han, S.-J.; Son, Y.-J.; Kim, B.-H. Association between diabetes mellitus and oral health status in patients with cardiovascular diseases: A nationwide population-based study. Int. J. Environ. Res. Public. Health 2021, 18, 4889. [Google Scholar] [CrossRef]
- Moon, M.-G.; Kang, S.-H.; Kim, S.-H.; Park, S.-Y.; Seol, Y.-J.; Yoon, C.-H.; Lee, H.-J.; Youn, T.-J.; Chae, I.-H.; Leira, Y.; et al. Association between toothbrushing and cardiovascular risk factors: A cross-sectional study using Korean National Health and Nutrition Examination Survey 2015–2017. BMC Oral Health 2024, 24, 4. [Google Scholar] [CrossRef]
- VanWormer, J.J.; Acharya, A.; Greenlee, R.T.; Nieto, F.J. Oral hygiene and cardiometabolic disease risk in the survey of the health of Wisconsin. Community Dent. Oral. Epidemiol. 2013, 41, 374–384. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Leveille, S.G.; Camhi, S.M.; Shi, L. Association of oral care with periodontitis and glycemic control among US adults with diabetes. BMC Oral. Health 2023, 23, 903. [Google Scholar] [CrossRef] [PubMed]
- Janket, S.-J.; Lee, C.; Surakka, M.; Jangam, T.G.; Van Dyke, T.E.; Baird, A.E.; Meurman, J.H. Oral hygiene, mouthwash usage and cardiovascular mortality during 18.8 years of follow-up. Br. Dent. J. 2023, 3, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Jain, R.; Roy, P.; Thomas, A.M.; Kaur, P.; Pandian, J.D. Periodontal disease and oral hygiene practices in patients with ischemic stroke. Chrismed J. Health Res. 2015, 2, 203–207. [Google Scholar]
- Patel, J.; Kulkarni, S.; Doshi, D.; Poddar, P.; Srilatha, A.; Reddy, K.S. Periodontal disease among non-diabetic Coronary Heart Disease patients. A case-control study. Acta Bio-Medica Ateneo Parm. 2021, 92, e2021030. [Google Scholar] [CrossRef]
- Cinar, A.B.; Oktay, I.; Schou, L. Relationship between oral health, diabetes management and sleep apnea. Clin. Oral. Investig. 2013, 17, 967–974. [Google Scholar] [CrossRef]
- Afsar, B. Sociodemographic, clinical, and laboratory parameters related with presence of regular toothbrushing in hemodialysis patients. Ren. Fail. 2013, 35, 179–184. [Google Scholar] [CrossRef]
- Hiramatsu, T.; Okumura, S.; Iguchi, D.; Kojima, H. Higher dental care is positively associated with key prognosis factors in peritoneal dialysis patients: Findings from a retrospective study. Ren. Replace. Ther. 2022, 8, 6. [Google Scholar] [CrossRef]
- Saengtipbovorn, S.; Taneepanichskul, S. Effectiveness of lifestyle change plus dental care (LCDC) program on improving glycemic and periodontal status in the elderly with type 2 diabetes. BMC Oral. Health 2014, 14, 72. [Google Scholar] [CrossRef]
- Cinar, A.B.; Schou, L. Impact of empowerment on toothbrushing and diabetes management. Oral. Health Prev. Dent. 2014, 12, 337–344. [Google Scholar] [CrossRef]
- Kaur, J.; Grover, V.; Gupta, J.; Gupta, M.; Kapur, V.; Mehta, M.; Lyle, D.M.; Samujh, T.; Jain, A. Effectiveness of subgingival irrigation and powered toothbrush as home care maintenance protocol in type 2 diabetic patients with active periodontal disease: A 4-month randomized controlled trial. J. Ind. Soc. Periodontol. 2023, 27, 515–523. [Google Scholar] [CrossRef] [PubMed]
- McGuinness, L.A.; Higgins, J.P.T. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res. Synth. Methods 2021, 12, 55–61. [Google Scholar] [CrossRef] [PubMed]
- Stanimirovic, J.; Radovanovic, J.; Banjac, K.; Obradovic, M.; Essack, M.; Zafirovic, S.; Gluvic, Z.; Gojobori, T.; Isenovic, E.R. Role of C-Reactive Protein in Diabetic Inflammation. Mediat. Inflamm. 2022, 2022, 3706508. [Google Scholar] [CrossRef]
- Pant, S.; Deshmukh, A.; GuruMurthy, G.S.; Pothineni, N.V.; Watts, T.E.; Romeo, F.; Mehta, J.L. Inflammation and Atherosclerosis—Revisited. J. Cardiovasc. Pharmacol. Ther. 2014, 19, 170–178. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Chen, J.; Lan, H.; Tang, Y. Role of C-Reactive Protein in Kidney Diseases. Kidney Dis. 2022, 9, 73–81. [Google Scholar] [CrossRef] [PubMed]
- Shang, Q.; Gao, Y.; Qin, T.; Wang, S.; Shi, Y.; Chen, T. Interaction of Oral and Toothbrush Microbiota Affects Oral Cavity Health. Front. Cell. Infect. Microbiol. 2020, 10, 17. [Google Scholar] [CrossRef]
- Deo, P.N.; Deshmukh, R. Oral microbiome: Unveiling the fundamentals. J. Oral. Maxillofac. Pathol. 2019, 23, 122–128. [Google Scholar] [CrossRef]
- Marcotte, H.; Lavoie, M.C. Oral Microbial Ecology and the Role of Salivary Immunoglobulin A. Microbiol. Mol. Biol. Rev. 1998, 62, 71–109. [Google Scholar] [CrossRef]
- Bollero, P.; Di Renzo, L.; Franco, R.; Rampello, T.; Pujia, A.; Merra, G.; De Lorenzo, A.; Docimo, R. Effects of new probiotic mouthwash in patients with diabetes mellitus and cardiovascular diseases. Eur. Rev. Med. Pharmacol. Sci. 2017, 21, 5827–5836. [Google Scholar] [CrossRef]
- Mente, A.; Dehghan, M.; Rangarajan, S.; O’Donnell, M.; Hu, W.; Dagenais, G.; Wielgosz, A.; Lear, A.S.; Wei, L.; Diaz, R.; et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur. Heart J. 2023, 44, 2560–2579. [Google Scholar] [CrossRef]
- Kazemi, A.; Sasani, N.; Mokhtari, Z.; Keshtkar, A.; Babajafari, S.; Poustchi, H.; Hashemian, M.; Malekzadeh, R. Comparing the risk of cardiovascular diseases and all-cause mortality in four lifestyles with a combination of high/low physical activity and healthy/unhealthy diet: A prospective cohort study. Int. J. Behav. Nutr. Phys. Act. 2022, 19, 138. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

